CARLSBAD, Calif.--(BUSINESS
WIRE)--Feb. 8, 2008--U.S.
Microbics (OTCBB: BUGSE
-
News), a business
enhancement firm for
companies with products,
services and initiatives
that favorably impact the
environment, announced that
it is reorganizing its
corporate structure,
announcing a
recapitalization, and a new
name for future business
operations. All changes are
scheduled to be completed in
the next ninety days and
shareholders will receive
notices effecting the
changes, but are not
required to vote on the
changes.
The Board of Directors of
U.S. Microbics, Inc has
determined that it is in the
best interests of the
company to change the state
of incorporation from
Colorado to Nevada. The
reincorporation will be
effected pursuant to a
merger agreement with Green
Mountain Holding
Corporation, a wholly owned
subsidiary of U.S. Microbics,
Inc. Upon the effectiveness
of the reincorporation, U.S.
Microbics, Inc. will cease
to exist and Green Mountain
Holding Corporation will
continue to operate the
company’s
business.
Upon the effectiveness of
the reincorporation, for
every 1,000 shares of U.S.
Microbics, Inc. common stock
held, a shareholder will be
entitled to 1 share of Green
Mountain Holding
Corporation, (GMHC) common
stock. Immediately following
the reincorporation, GMHC
will consummate a 10 for 1
forward stock split of its
common stock. A shareholder
record date for the
reverse/forward stock split
will be announced in the
near future.
Based upon the information
available to the company,
the number of shareholders
of record of the company’s
common stock will be reduced
to fewer than 500 as a
result of the
reincorporation stock
exchange and forward split,
and the company intends to
file a Form 15 with the
Securities and Exchange
Commission (SEC) in order to
terminate the registration
of its common stock under
the Exchange Act. Upon the
filing of the Form 15 and a
ninety day waiting period,
the Company will no longer
be required to file periodic
reports with the SEC,
including annual reports on
Form 10K and quarterly
reports on Form 10Q and will
no longer be subject to the
SEC’s
proxy rules. GMHC’s
common stock will become
listed on the pink sheets
under a new trading symbol
and GMHC will provide
reports as to its financial
condition and results of
operations may be accessed
at
www.pinksheets.com.
In conjunction with these
changes, the company has
established Green Mountain
Capital Group, Inc., (GMGC),
a wholly owned subsidiary,
whose mission is to be the
number one provider of
creative growth strategies
for client companies who
provide products and
services that favorably
impact the environment. A
product and service profile
is available at
www.greenmountaincapitalgroup.com.
Current clients of USM
Capital Group, Inc. will be
serviced by GMCG staff.
Robert Brehm, CEO,
commented,
“The
changes announced today
focus our core competencies
together into two
environmental sectors,
namely environmental
technology and environmental
capital formation and
management. There is
tremendous growth potential
in both of these sectors as
a result of the Green
Awakening movement and we
are generating revenue in
each one today. We have
invested heavily in
technology and environmental
business development over
the past 10 years and now
our investment is about to
pay off because we are
uniquely positioned to offer
our services, skills, and
experience with a seasoned
financial network and
knowledge base that other
companies simply don’t
have. Our time is now, our
people are ready and our
client base is expanding as
we provide creative
solutions to companies with
products, services or
initiatives that favorably
impact the environment.”
About U.S. Microbics Inc.
U.S. Microbics is a business
enhancement company that
develops creative growth
strategies for client
companies providing
eco-friendly products and
services that favorably
impact the environment.
For more information on the
company, contact Robert
Brehm at 760-918-1860 x102
or visit the website at
www.greenmountaincapitalgroup.com.
The information contained in
this press release includes
forward-looking statements.
Forward-looking statements
usually contain the words
``estimate,''
``anticipate,'' ``believe,''
``expect,'' or similar
expressions that involve
risks and uncertainties.
These risks and
uncertainties include the
Company's status as a
startup company with
uncertain profitability,
need for significant
capital, uncertainty
concerning market acceptance
of its products,
competition, limited service
and manufacturing
facilities, dependence on
technological developments
and protection of its
intellectual property. The
Company's actual results
could differ materially from
those discussed herein.
Factors that could cause or
contribute to such
differences are discussed
more fully in the ``Risk
Factors,'' ``Management's
Discussion and Analysis or
Plan of Operation'' and
other sections of the
Company's Form 10-KSB and
other publicly available
information regarding the
Company on file with the
Securities and Exchange
Commission. The Company will
provide you with copies of
this information upon
request.
Contact:
U.S. Microbics Inc.
Robert Brehm, 760-918-1860 x102
Source: U.S. Microbics Inc.